Patent · US Active

Therapeutic compounds and compositions

US9108921B2 · kind B2 · utility

21Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2014
Grant dateAug 18, 2015
Priority date
Expiry dateMar 14, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/65583
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of general formula I:and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.